netFormulary
 Report : A-Z HCD items in Formulary 23/10/2017 23:39:44
[Back]
 
Section Status HCD Name
10.01.03 Formulary Cancer Drugs Fund Abatacept Orencia®
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone Actetate  Zytiga®
01.05.03 Formulary Cancer Drugs Fund Adalimumab Humira®
10.01.03 Formulary Cancer Drugs Fund Adalimumab Humira®
13.05.03 Formulary Cancer Drugs Fund Adalimumab Humira®
08.01.05 Formulary Cancer Drugs Fund Afatinib 
11.08.02 Formulary Cancer Drugs Fund Aflibercept intravitreal injection Eylea
08.02.03 Formulary Cancer Drugs Fund Alemtuzumab Lemtrada®
02.14 Restricted Use Cancer Drugs Fund Alirocumab  Praluent®
10.01.03 Restricted Use Cancer Drugs Fund Apremilast Otezla®
08.01.05 Formulary Cancer Drugs Fund Axitinib Inlyta®
08.01.03 Formulary Cancer Drugs Fund Azacitidine Vidaza®
10.01.03 Formulary Cancer Drugs Fund Belimumab Benlysta®
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin®
11.08.02 Formulary Cancer Drugs Fund Bevacizumab intravitreal injection Avastin®
08.01.05 Formulary Cancer Drugs Fund Blinatumomab Blincyto®
05.03.03 Formulary Cancer Drugs Fund Boceprevir Victrelis®
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade®
08.01.05 Formulary Cancer Drugs Fund Bosutinib  Bosulif®
04.09.03 Formulary Cancer Drugs Fund Botulinum Toxin Type A Xeomin®
04.09.03 Formulary Cancer Drugs Fund Botulinum Toxin Type A Botox®
04.09.03 Formulary Cancer Drugs Fund Botulinum Toxin Type A Dysport®
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris®
08.01.05 Restricted Use Cancer Drugs Fund Cabazitaxel 
08.01.05 Restricted Use Cancer Drugs Fund Ceritinib Zykadia®
10.01.03 Formulary Cancer Drugs Fund Certolizumab Pegol Cimzia®
08.01.05 Restricted Use Cancer Drugs Fund Cetuximab Erbitux®
05.01.07 Formulary Cancer Drugs Fund Colistimethate sodium nebuliser 
08.01.05 Formulary Cancer Drugs Fund Crizotinib  Xalkori®
08.01.05 Formulary Cancer Drugs Fund Dabrafenib  Tafinlar ®
05.03.03.02 Formulary Cancer Drugs Fund Daclatasvir  Daklinza®
09.01.03 Formulary Cancer Drugs Fund Darbepoetin Alfa Aranesp®
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel®
11.04.01 Restricted Use Cancer Drugs Fund Dexamethasone intravitreal implant Ozurdex®
08.02.04 Formulary Cancer Drugs Fund Dimethyl fumarate Tecfidera ®
05.03.01 Restricted Use Cancer Drugs Fund Elbasvir & Grazoprevir. Zepatier ®
09.01.04 Formulary Cancer Drugs Fund Eltrombopag Revolade®
05.03.03 Formulary Cancer Drugs Fund Entecavir Baraclude®
08.01.05 Formulary Cancer Drugs Fund Enzalutamide Xtandi®
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven® Solution for Injection
08.01.05 Formulary Cancer Drugs Fund Erlotinib Tarceva®
10.01.03 Formulary Cancer Drugs Fund Etanercept Enbrel®, Benepali®
08.01.05 Restricted Use Cancer Drugs Fund Everolimus Afinitor®
02.14 Restricted Use Cancer Drugs Fund Evolocumab  Repatha®
08.02.04 Formulary Cancer Drugs Fund Fingolimod 
11.04.01 Restricted Use Cancer Drugs Fund Fluocinolone intravitreal implant Iluvien®
08.01.05 Restricted Use Cancer Drugs Fund Gefitinib Iressa®
01.05.03 Formulary Cancer Drugs Fund Golimumab Simponi®
10.01.03 Formulary Cancer Drugs Fund Golimumab Simponi®
08.01.05 Restricted Use Cancer Drugs Fund Ibrutinib Imbruvica®
08.01.05 Formulary Cancer Drugs Fund Idelalisib Zydelig®
08.01.05 Formulary Cancer Drugs Fund Imatinib Gilvec®
01.05.03 Formulary Cancer Drugs Fund Infliximab Remicade® / Inflectra® / Remsima®
10.01.03 Formulary Cancer Drugs Fund Infliximab Remicade®, Remsima®, Inflectra®
08.02.04 Formulary Cancer Drugs Fund Interferon Alfa Viraferon®
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy®
13.05.03 Restricted Use Cancer Drugs Fund Ixekizumab  Taltz®
08.01.05 Formulary Cancer Drugs Fund Lapatinib Tyverb®
05.03.03.02 Formulary Cancer Drugs Fund Ledipasvir & Sofosbuvir Harvoni®
08.02.04 Formulary Cancer Drugs Fund Lenalidomide 
03.04.02 Restricted Use Cancer Drugs Fund Mepolizumab Nucala®
08.01.05 Restricted Use Cancer Drugs Fund Necitumumab  Portrazza®
08.01.05 Formulary Cancer Drugs Fund Nilotinib Tasigna®
08.01.05 Formulary Cancer Drugs Fund Nintedanib Ofev®
08.01.05 Restricted Use Cancer Drugs Fund Nintedanib Vargatef®
08.01.05 Restricted Use Cancer Drugs Fund Nivolumab  Opdivo®
01.09.01 Restricted Use Cancer Drugs Fund Obeticholic acid Ocaliva®
08.01.05 Formulary Cancer Drugs Fund Obinutuzumab Gazyvaro®
08.01.05 Formulary Cancer Drugs Fund Ofatumumab Arzerra®
08.01.05 Formulary Cancer Drugs Fund Olaparib Lynparza®
03.04.02 Formulary Cancer Drugs Fund Omalizumab Xolair®
05.03.03.02 Formulary Cancer Drugs Fund Ombitasvir + paritaprevir + Ritonavir Viekirax®
08.01.05 Restricted Use Cancer Drugs Fund Osimertinib  TAGRISSO®
08.01.05 Non Formulary Cancer Drugs Fund Paclitaxel Albumin Abraxane®
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix®
08.01.05 Formulary Cancer Drugs Fund Panobinostat Farydak®
08.01.05 Restricted Use Cancer Drugs Fund Pazopanib Votrient®
08.01.05 Restricted Use Cancer Drugs Fund Pegaspargase Oncaspar®
08.02.04 Formulary Cancer Drugs Fund Peginterferon Alfa PegIntron®
08.02.04 Formulary Cancer Drugs Fund Peginterferon Alfa Pegasys®
08.02.04 Formulary Cancer Drugs Fund Peginterferon Alfa ViraferonPeg®
08.02.04 Formulary Cancer Drugs Fund Peginterferon Beta PegIntron®
08.01.02 Formulary Cancer Drugs Fund Pegylated Liposomal Doxorubicin Hydrochloride 
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda®
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta®
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta® Concentrate for Solution for Infusion
08.01.02 Formulary Cancer Drugs Fund Pixantrone Pixuvri® solution for infusion
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid®
08.01.05 Formulary Cancer Drugs Fund Ponatinib  Iclusig ®
08.01 Restricted Use Cancer Drugs Fund Radium-223 Xofigo® solution for injection
08.01.05 Restricted Use Cancer Drugs Fund Ramucirumab Cyramza ®
11.08.02 Formulary Cancer Drugs Fund Ranibizumab Lucentis®
08.02.03 Formulary Cancer Drugs Fund Rituximab MabThera® / Truxima®
10.01.03 Formulary Cancer Drugs Fund Rituximab (rheumatology) MabThera® / Truxima®
09.01.04 Formulary Cancer Drugs Fund Romiplostim Nplate®
08.01.05 Formulary Cancer Drugs Fund Ruxolitinib Jakavi®
10.01.03 Formulary Cancer Drugs Fund Secukinumab Cosentyx ®
05.03.03.02 Formulary Cancer Drugs Fund Simeprevir Olysio®
05.03.03.02 Formulary Cancer Drugs Fund Sofosbuvir Sovaldi®
05.03.03.02 Formulary Cancer Drugs Fund Sofosbuvir + Velpatasvir Epclusa®
08.01.05 Restricted Use Cancer Drugs Fund Sunitinib Sutent®
08.02.04 Restricted Use Cancer Drugs Fund Talimogene  Imlygic®
05.03.03 Formulary Cancer Drugs Fund Telaprevir Incivo®
05.03.01 Formulary Cancer Drugs Fund Tenofovir Disproxil Viread®
08.02.04 Formulary Cancer Drugs Fund Teriflunomide  Aubagio®
08.02.04 Formulary Cancer Drugs Fund Thalidomide Pharmion®
10.01.03 Formulary Cancer Drugs Fund Tocilizumab RoActemra®
06.05.02 Formulary Cancer Drugs Fund Tolvaptan Samsca®
08.01.05 Formulary Cancer Drugs Fund Trabectedin Yondelis®
08.01.05 Restricted Use Cancer Drugs Fund Trametinib  Mekinist®
08.01.05 Formulary Cancer Drugs Fund Trastuzumab Herceptin®
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine Kadcyla®
01.05.03 Formulary Cancer Drugs Fund Ustekinumab Stelara®
10.01.03 Formulary Cancer Drugs Fund Ustekinumab Stelara®
13.05.03 Formulary Cancer Drugs Fund Ustekinumab Stelara®
01.05.03 Formulary Cancer Drugs Fund Vedolizumab Entyvio®
Berkshire West NHS